Gene: EMID1
Official Full Name: EMI domain containing 1provided by HGNC
Gene Summary: Predicted to be located in several cellular components, including Golgi apparatus; endoplasmic reticulum; and extracellular matrix. Predicted to be part of collagen trimer. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO26700 | EMID1 Knockout cell line (HCT 116) | Human | EMID1 | 1:2~1:4 | Negative | Online Inquiry |
KO26701 | EMID1 Knockout cell line (HEK293) | Human | EMID1 | 1:3~1:6 | Negative | Online Inquiry |
EMID1 Gene Knockout Cell Lines are a specialized biological product designed for advanced research in genetics and molecular biology. These cell lines are engineered to have a targeted deletion of the EMID1 gene, which is critical for the study of its function in cellular processes such as migration, invasion, and tumorigenesis. By eliminating the EMID1 gene, researchers can observe and analyze the resulting phenotypic changes, thus gaining insights into the gene's role in health and disease pathways.
The knockout mechanism is facilitated through cutting-edge CRISPR-Cas9 technology, which allows for precise genomic edits. This enables scientists to create a controlled environment where the influence of the EMID1 gene can be systematically assessed, thus providing valuable data regarding its contribution to various biological functions. The implications of such research are vast, particularly in understanding cancer biology, where EMID1 may play a significant role in cell proliferation and metastatic behavior.
The scientific importance of EMID1 Gene Knockout Cell Lines extends beyond basic research. These models can be utilized in preclinical drug testing, facilitating the identification of potential therapeutic targets that could mitigate the effects of diseases linked to EMID1 dysregulation. Furthermore, they serve as a robust platform for screening small molecules and assessing their effects on cellular behavior, thereby accelerating the drug discovery process.
One of the unique selling points of EMID1 Gene Knockout Cell Lines is their unparalleled specificity and reliability. Unlike general knockdown techniques, which may only reduce gene expression and carry the risk of off-target effects, these knockout lines achieve a complete loss of function, offering a clearer understanding of gene-linked pathways. This precision, paired with a validated performance in various assay systems, makes them an invaluable tool for both researchers and clinicians focused on uncovering the intricacies of gene function.
Researchers and clinicians will find considerable value in EMID1 Gene Knockout Cell Lines due to their reproducibility, ease of use, and applicability across various experimental designs. By integrating these cell lines into their studies, users can enhance the quality of their findings, thereby contributing to advancements in genetic research and therapeutic strategies.
Our company prides itself on a commitment to excellence in the development of biological products, with a strong foundation in genetic engineering and cellular assays. Our expertise ensures that you receive not only highly functional products but also unparalleled support and resources to aid your research endeavors.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.